Zobrazeno 1 - 10
of 35
pro vyhledávání: '"59"'
Autor:
Susan E Krown, Carlee B Moser, Patrick MacPhail, Roy M Matining, Catherine Godfrey, Stephanie R Caruso, Mina C Hosseinipour, Wadzanai Samaneka, Mulinda Nyirenda, Naftali W Busakhala, Fred M Okuku, Josphat Kosgei, Brenda Hoagland, Noluthando Mwelase, Vincent O Oliver, Henriette Burger, Rosie Mngqibisa, Mostafa Nokta, Thomas B Campbell, Margaret Z Borok, Agnes Moses, Cecilia Kanyama, Pamela Mukwekwerere, Ivy Gudza, Felluna Chauwa, Godwin Ulaya, Irene Kutto, Priscilla Cheruiyot, Clement Okello, Annet Nakaganda, Geoffrey Koskei, Winnie Keter, Juliana Netto, Tamiris Baião, Iveshni Govender, Jessica O'Connell-Maritz, Kevin Cain, John Okanda, Lynne Cornelissen, Marije Van Schalkwyk, Rejoice Sikhosana, Minenhle Ngcobo, Jeannette Y. Lee, Taylor Harrison, William Wachsman, Katherine Shin, Scott Evans, Jennifer Rothenberg, Lara Hosey, Sean McCarthy, Otoniel Martinez-Maza, Charles Rinaldo, Dirk Dittmer, Courtney Fletcher, Michelle Rudek, Aida Asmelash, Valery Hughes, Jeffrey Schouten, David Shugarts, Tapiwanashe Kujinga, Amanda Zadzilka, Fredrick Kerui, Debora Robertson, James Rooney, Krishna Sewal, Brian Gottshall
Publikováno v:
The Lancet. 395:1195-1207
Summary Background Optimal treatment regimens for AIDS-associated Kaposi sarcoma, a frequent contributor to morbidity and mortality among people with HIV, have not been systematically evaluated in low-income and middle-income countries, where the dis
Autor:
Sheila Raghavan, Mohamed Cherine Ramadan, Berna Dilbaz, Rasha Dabash, Nguyen Thi Nhu Ngoc, Beverly Winikoff, Ayisha Diop, Serdar Yalvac, Blami Dao, Jill Durocher, Jennifer Blum, Ilana G. Dzuba
Publikováno v:
The Lancet. 375:217-223
Summary Background Oxytocin, the gold-standard treatment for post-partum haemorrhage, needs refrigeration, intravenous infusion, and skilled providers for optimum use. Misoprostol, a potential alternative, is increasingly used ad hoc for treatment of
Autor:
Doron Zahger, Shlomi Matetzky, Bojan Cercek, Marko Noc, Prediman K. Shah, Peter R. Mahrer, Gerald Maurer, Uwe Zeymer
Publikováno v:
The Lancet. 361:809-813
Summary Background There is serological and epidemiological evidence of an association between Chlamydia pneumoniae infection and coronary artery disease. Results of previous smaller studies have indicated a reduction of recurrent ischaemic events in
Autor:
Chan Joon Kim, Mahn-Won Park, Min Chul Kim, Eun-Ho Choo, Byung-Hee Hwang, Kwan Yong Lee, Yun Seok Choi, Hee-Yeol Kim, Ki-Dong Yoo, Doo-Soo Jeon, Eun-Seok Shin, Young-Hoon Jeong, Ki-Bae Seung, Myung Ho Jeong, Hyeon Woo Yim, Youngkeun Ahn, Kiyuk Chang, Yong-Hoon Jeong, Myung Ho Jeon, Ju-Hyeon Oh, Sang Jin Ha, Ju Yeol Baek, Kyung Tae Jung, Joon-Hyung Doh, Won Kim, Dong-Bin Kim, Kwang Soo Cha, Myeong-Ho Yoon, Seung-Ho Hur, Seung-Hwan Lee, Byung-Ryul Cho, Jong-Seon Park, Jin Shin Koh, Sang-Hyun Kim, Jang Hyun Cho, Byung Joo Shim, Sang Wook Kim, Jae-Sik Jang, Kee-Sik Kim, Won-Yong Shin, Ki-Chul Sung
Publikováno v:
The Lancet. 398:1305-1316
Summary Background In patients with acute myocardial infarction receiving potent antiplatelet therapy, the bleeding risk remains high during the maintenance phase. We sought data on a uniform unguided de-escalation strategy of dual antiplatelet thera
Autor:
Mark Nelson, John Chalmers, Michael Burke, Bruce Neal, Dan Xu, D. Wynne, Ruth Webster, Peter Hay, Shirley Jansen, Armand Edison, Andrew Black, Mark Bloch, Aravinda Thiagalingam, Graham S Hillis, Angalie E Abraham, Kris Rogers, Tim Usherwood, M. Altman, Markus P. Schlaich, Sinjini Biswas, Emily Atkins, Clara K Chow, Janis M. Nolde, Gemma A. Figtree, Anushka Patel, Harry Klimis, Jay Thakkar, Christopher M. Reid, Andrew E. Ajani, Laurent Billot, Revathy Carnagarin, Anthony Rodgers, Andrew Hung
Publikováno v:
The Lancet. 398:1043-1052
Treatment inertia is a recognised barrier to blood pressure control, and simpler, more effective treatment strategies are needed. We hypothesised that a hypertension management strategy starting with a single pill containing ultra-low-dose quadruple
Autor:
Gerd R Burmester, Frank Buttgereit, Corrado Bernasconi, Jose M Álvaro-Gracia, Nidia Castro, Maxime Dougados, Cem Gabay, Jacob M van Laar, Jan Michael Nebesky, Attila Pethoe-Schramm, Carlo Salvarani, Marc Y Donath, Markus R John, Arnaud Constantin, Jacques Eric Gottenberg, Sylvie Loiseau-Peres, Minh Nguyen, Thierry Schaeverbeke, Rieke H.-E. Alten, Christopher Amberger, Werner A. Biewer, Konrad Boche, Gerd Ruediger Burmester, Andreas Engel, Martin Feuchtenberger, Martin Fleck, Georg Gauler, Bernhard Heilig, Maria Höhle, Christof Iking-Konert, Peter Kästner, David Kofler, Klaus Krueger, Cornelia Kühne, Reiner Kurthen, Hendrik Schulze-Koops, Holger Schwenke, Maren Sieburg, Christof Specker, Hans-Peter Tony, Siegfried Wassenberg, Jörg Wendler, Roberto Caporali, Oscar Epis, Marco Matucci-Cerinic, Alexander Dubikov, Rimma Kamalova, Maxim Korolev, Vadim I. Mazurov, Ekaterina Puntus, Nemanja Damjanov, Tatjana Ilic, Milijanka Lazarevic, Sasa Milenkovic, Milan Petronijevic, Elyes Bouajina, Mohamed Elleuch
Publikováno v:
The Lancet, Vol. 396, No 10246 (2020) pp. 267-276
Summary Background Patients with inflammatory diseases, such as rheumatoid arthritis, often receive glucocorticoids, but long-term use can produce adverse effects. Evidence from randomised controlled trials to guide tapering of oral glucocorticoids i
Autor:
Francois, Raffi, Anita, Rachlis, Hans-Jürgen, Stellbrink, W David, Hardy, Carlo, Torti, Chloe, Orkin, Mark, Bloch, Daniel, Podzamczer, Vadim, Pokrovsky, Federico, Pulido, Steve, Almond, David, Margolis, Clare, Brennan, Sherene, Min, B, Young
Publikováno v:
The Lancet. 381:735-743
Summary Background Dolutegravir (S/GSK1349572) is a once-daily HIV integrase inhibitor with potent antiviral activity and a favourable safety profile. We compared dolutegravir with HIV integrase inhibitor raltegravir, as initial treatment for adults
Autor:
Lisa Porter, Sylvia K. Shenouda, Guntram Schernthaner, Mark Fineman, Cory R. Heilmann, Michael A. Nauck, Aijun Gao, Thomas Forst, Wayne Huey-Herng Sheu, John B. Buse, Byron J. Hoogwerf, Marilyn K. Boardman
Publikováno v:
The Lancet. 381:117-124
Glucagon-like peptide-1 receptor agonists exenatide and liraglutide have been shown to improve glycaemic control and reduce bodyweight in patients with type 2 diabetes. We compared the efficacy and safety of exenatide once weekly with liraglutide onc
Autor:
Lin Lu, Yanping Bao, Ru-Jia Wang, Zhi Lian, Jun Ma, Meng-Fan Su, Jie Shi, Tong-Yu Wang, Mo-Xuan Liu
Publikováno v:
The Lancet. 390:S14
Background Substance use in young people is a global problem, with potential adverse effects on physical, mental, and social wellbeing. The situation of substance use varies geographically worldwide. We did a systematic review and meta-analysis to qu
Autor:
Henning Bliddal, Arne Astrup, Else Marie Bartels, Robin Christensen, Pernelle Kruse Kristensen
Publikováno v:
The Lancet. 370:1706-1713
Since the prevalence of obesity continues to increase, there is a demand for effective and safe anti-obesity agents that can produce and maintain weight loss and improve comorbidity. We did a meta-analysis of all published randomised controlled trial